dr. kolberg on ensuring confidence with biosimilars in oncology
Published 5 years ago • 62 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
2:17
dr. kolberg explains the approval process for biosimilars
-
0:53
dr. martin on provider confidence with biosimilars in oncology
-
1:48
dr. markman on the concept of biosimilars in oncology
-
1:09
dr. kolberg provides a global perspective on biosimilar integration
-
1:33
dr. kolberg discusses considerations with fda-approved biosimilars
-
57:41
webinar: biologics & biosimilars
-
4:12
the basics of biosimilars
-
4:09
better understanding biosimilar medications
-
1:17
dr. kolberg discusses the lilac study of abp 980
-
1:55
dr. kolberg on collecting real-world biosimilar trastuzumab data in breast cancer
-
2:27
dr. kolberg on the safety profile of trastuzumab biosimilars in breast cancer
-
1:15
dr. kolberg discusses the central pathology review of abp 980
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
1:05
dr. schwartzberg on increasing competition with biosimilars in oncology
-
7:20
biosimilars in oncology: addressing awareness
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
0:41
similarity of biosimilars and biologics
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
1:56
dr. kolberg on the lilac study in breast cancer
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
5:56
the complexity of choosing biosimilars in oncology